Dr Woodrow Wilson Brand Iii, MD | |
806 Earl Frye Blvd, Amory, MS 38821 | |
(662) 256-8479 | |
(662) 256-1177 |
Full Name | Dr Woodrow Wilson Brand Iii |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 31 Years |
Location | 806 Earl Frye Blvd, Amory, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053492645 | NPI | - | NPPES |
009306530 | Medicaid | AL | |
0111887 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 12093 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Clay County Medical Corporation | West point, MS | Hospital |
North Mississippi Medical Center | Tupelo, MS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Clay County Medical Corporation | 4789649609 | 26 |
News Archive
The University of Texas MD Anderson Cancer Center today signed a sister institution agreement with the National Cancer Institute of Peru. Also known as the Instituto Nacional de Enfermedades Neoplásicas, INEN is Peru's sole national referral center for cancer.
BioInformatics LLC has announced the release of their latest report, The Market for Cell-Based Assays.
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
The American Journal of Preventive Medicine, published by Elsevier, is committed to publishing the most robust, evidence-based research and commentary on COVID-19 as they unfold to keep readers up to date and aware of issues relevant to community and individual health during this continually evolving global outbreak.
Acute heart attacks can be successfully treated through a multidisciplinary team approach involving Emergency Medical Services, emergency physicians, cardiologists and specialty centres, according to a study conducted by Dr. Jacobus S. de Villiers and colleagues in Calgary.
› Verified 2 days ago
Entity Name | Clay County Medical Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1578670972 PECOS PAC ID: 4789649609 Enrollment ID: O20041119000718 |
News Archive
The University of Texas MD Anderson Cancer Center today signed a sister institution agreement with the National Cancer Institute of Peru. Also known as the Instituto Nacional de Enfermedades Neoplásicas, INEN is Peru's sole national referral center for cancer.
BioInformatics LLC has announced the release of their latest report, The Market for Cell-Based Assays.
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
The American Journal of Preventive Medicine, published by Elsevier, is committed to publishing the most robust, evidence-based research and commentary on COVID-19 as they unfold to keep readers up to date and aware of issues relevant to community and individual health during this continually evolving global outbreak.
Acute heart attacks can be successfully treated through a multidisciplinary team approach involving Emergency Medical Services, emergency physicians, cardiologists and specialty centres, according to a study conducted by Dr. Jacobus S. de Villiers and colleagues in Calgary.
› Verified 2 days ago
Entity Name | Boa Vida Hospital Of Aberdeen Ms Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710405741 PECOS PAC ID: 0244505840 Enrollment ID: O20171128003460 |
News Archive
The University of Texas MD Anderson Cancer Center today signed a sister institution agreement with the National Cancer Institute of Peru. Also known as the Instituto Nacional de Enfermedades Neoplásicas, INEN is Peru's sole national referral center for cancer.
BioInformatics LLC has announced the release of their latest report, The Market for Cell-Based Assays.
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
The American Journal of Preventive Medicine, published by Elsevier, is committed to publishing the most robust, evidence-based research and commentary on COVID-19 as they unfold to keep readers up to date and aware of issues relevant to community and individual health during this continually evolving global outbreak.
Acute heart attacks can be successfully treated through a multidisciplinary team approach involving Emergency Medical Services, emergency physicians, cardiologists and specialty centres, according to a study conducted by Dr. Jacobus S. de Villiers and colleagues in Calgary.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Woodrow Wilson Brand Iii, MD 10996 Four Seasons Pl, Ste 100a, Crown Point, IN 46307-8685 Ph: (662) 256-8479 | Dr Woodrow Wilson Brand Iii, MD 806 Earl Frye Blvd, Amory, MS 38821 Ph: (662) 256-8479 |
News Archive
The University of Texas MD Anderson Cancer Center today signed a sister institution agreement with the National Cancer Institute of Peru. Also known as the Instituto Nacional de Enfermedades Neoplásicas, INEN is Peru's sole national referral center for cancer.
BioInformatics LLC has announced the release of their latest report, The Market for Cell-Based Assays.
OncoGenex Pharmaceuticals, Inc. announced today publication of results from a randomized Phase 2 trial in the Journal of Clinical Oncology. The trial results showed a survival benefit with the investigational agent OGX-011/TV1011 (custirsen) in patients with advanced prostate cancer. The median overall survival for patients who were treated with custirsen plus first-line docetaxel/prednisone was 23.8 months compared to 16.9 months for patients treated with docetaxel/prednisone alone.
The American Journal of Preventive Medicine, published by Elsevier, is committed to publishing the most robust, evidence-based research and commentary on COVID-19 as they unfold to keep readers up to date and aware of issues relevant to community and individual health during this continually evolving global outbreak.
Acute heart attacks can be successfully treated through a multidisciplinary team approach involving Emergency Medical Services, emergency physicians, cardiologists and specialty centres, according to a study conducted by Dr. Jacobus S. de Villiers and colleagues in Calgary.
› Verified 2 days ago
Dr. Hoat Minh Hoang, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 806 Earl Frye Blvd, Amory, MS 38821 Phone: 662-256-8479 Fax: 662-256-1177 | |
Almaz Kurbanov, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1127 Earl Frye Blvd Ste B, Amory, MS 38821 Phone: 662-256-3333 | |
Kirk Allan Caddell, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1127 Earl Frye Blvd, Suite B, Amory, MS 38821 Phone: 662-256-3333 Fax: 662-256-5166 |